Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review

被引：0
|
作者：
Katherine Mackey
Stephanie Veazie
Johanna Anderson
Donald Bourne
Kim Peterson
机构：
[1] VA Portland Health Care System,Evidence Synthesis Program (ESP) Coordinating Center
来源：
Journal of General Internal Medicine | 2020年 / 35卷
关键词：
opioid use disorder; buprenorphine; naltrexone; barriers; facilitators;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：954 / 963
页数：9
相关论文
共 50 条
  • [41] The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
    Russell, Cayley
    Law, Justine
    Imtiaz, Sameer
    Rehm, Juergen
    Le Foll, Bernard
    Ali, Farihah
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [42] Policies regarding use of medications for opioid use disorder in professional recovery programs: A scoping review
    White, Kelley M.
    Hill, Lucas G.
    Perez, Joshua C.
    Torrez, Sorina B.
    Zagorski, Claire M.
    Loera, Lindsey J.
    [J]. SUBSTANCE ABUSE, 2022, 43 (01) : 749 - 755
  • [43] The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
    Frost, Madeline C.
    Lampert, Hannah
    Tsui, Judith I.
    Iles-Shih, Matthew D.
    Williams, Emily C.
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [44] Physician's Attitudes Toward Patients With Opioid Use Disorder and Use of Medications for Opioid Use Disorder Vary by Training
    Bailey, Bridget C.
    Sweeney, Helen Anne
    Winstanley, Erin L.
    Lopez, Christopher
    Potts, Laura
    [J]. SUBSTANCE USE & ADDICTION JOURNAL, 2024,
  • [45] Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care
    Hooker, Stephanie A.
    Solberg, Leif I.
    Miley, Kathleen M.
    Borgert-Spaniol, Caitlin M.
    Rossom, Rebecca C.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2024, 37 (03) : 389 - 398
  • [46] Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings
    Speight, Chandra
    Caiola, Courtney
    Tyndall, Deborah E.
    Scott, Elaine S.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (02) : 112 - 121
  • [47] Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience
    Westafer, Lauren M.
    Beck, Samantha A.
    Simon, Caty
    Potee, Benjamin
    Soares, William E.
    Schoenfeld, Elizabeth M.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2024, 83 (04) : 340 - 350
  • [48] Barriers and Facilitators to Integrating Medications for Opioid Use Disorder (MOUD) and HIV Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults (AYA)
    Herrera, Maria
    Darien, Kaja
    Wood, Sarah
    Hadland, Scott
    Metzger, David
    Dowshen, Nadia
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [49] BARRIERS AND FACILITATORS TO INTEGRATING MEDICATIONS FOR OPIOID USE DISORDER (MOUD) AND HIV PRE-EXPOSURE PROPHYLAXIS (PREP) FORADOLESCENTS AND YOUNG ADULTS (AYA)
    Herrera, Maria Christina
    Darien, Kaja
    Wood, Sarah
    Hadland, Scott E.
    Dowshen, Nadia
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2023, 72 (03) : S89 - S89
  • [50] "Racial inequity in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use" (HD17)
    Hollander, Mara A. G.
    Donohue, Julie
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2020, 15 (SUPPL 2):
12345